Replies to post #177715 on Biotech Values

[DewDiligence]

I don't understand why PFE wants AZN in the first place, particularly at the price it seems willing to pay.

Aside from the seduction of paying a much lower corporate tax rate, there’s the “shark” mindset captured in John LaMattina’s write-up (#msg-101627780).